The sizeable new round follows the announcement of phase 1 data for its lead asset MET-097i in September, and according to ...

As the controlling shareholder of Novo Nordisk, a leading Danish pharmaceutical company, the takeover emerges amidst rising ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders. Dividend stocks have long been favored by investors for the income ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...

An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...

Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...

Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...

Cantor analysts said they found the bone mineral density changes when reviewing supplemental data that was published along ...

Eli Lilly has received approval to start selling its weight loss drug, Mounjaro, in Hong Kong as early as the ... A group of ...